To access all features and enjoy the full functionality of this site, please ensure your browser is up-to-date. For IE8 users, the most recent version is IE11.

TECNIS® Monofocal Toric IOL

Excellent Outcomes for Patients with Astigmatism

Empower your patients’ vision with proven optical quality. The TECNIS® Monofocal Toric IOL delivers the sharpest vision, best low-light performance and long-term sustainability for patients with astigmatism.

Optimize your outcomes with the TECNIS® Toric Calculator.

Get a grip on visual performance

High-quality performance is just as critical for patients with astigmatism. The TECNIS® Toric IOL not only delivers excellent spherical correction but beautifully sharp vision as well.

Excellent astigmatism correction meets superior image contrast:

  • 94% of eyes achieved ≤ 0.50 diopters of residual refractive cylinder*1
  • 88% of patients achieved monocular corrected distance visual acuity of 20/20 or better2
  • Higher image contrast with TECNIS® Toric IOLs3

MTF at 50 c/mm White, 5 mm Pupil3

Up to 31% improved image contrast.

MTF at 50 c/mm White, 3 mm Pupil3

Up to 16% improved image contrast.

Modular Transfer Function (MTF) is a measure of the amount of contrast transferred by the optics in a visual system. The higher the MTF value, the more contrast transferred to the image, resulting in higher image contrast. AcrySof is a trademark of Novartis AG Corp.

TECNIS® Toric IOLs are designed for real-world conditions, empowering you to deliver high-confidence driving at night without distance glasses**2 — as well as the best low-light performance for patients with astigmatism.

Difficulty With Driving at Night Without Glasses at 6 Months†3

91.9% of patients (ZCT150) reported no difficulty with night driving — without glasses.

Trust your outcomes to an IOL that delivers exceptional postoperative rotational stability, stunning visual performance and high patient satisfaction.

2.74° mean axis change between baseline and 6 months.2

Unlike another leading IOL, TECNIS® IOL material is not associated with glistenings,4-8 which can inhibit your patients’ vision. Glistenings cause light scatter, which can result in a reduction in image contrast.5-9

97% of patients would elect to have the TECNIS® Toric IOL again.2



ZCT150, ZCT225, ZCT300, ZCT400, ZCT450, ZCT525, ZCT600



+5.0 D to 34.0 D in 0.5 diopter increments


6.0 mm


Biconvex, anterior aspheric surface, posterior diffractive surface


UV-blocking hydrophobic acrylic

Refractive Index:

1.47 at 35° C

Chromatic Aberration (Abbe Number):


Edge Design:

ProTEC frosted, continuous 360° posterior square edge







Theoretical AC Depth:

5.7 mm

5.72 mm

Surgeon Factor:10

1.68 mm

1.96 mm


Overall Length:

13.0 mm


Tri-Fix design, modified C, integral with optic


UV-blocking hydrophobic acrylic


Haptics offset from optic

View full product specifications (PDF)


*In a separate (IDE) study, 72.3% of ZCT150 eyes achieved ≤ 0.50 diopters of residual refractive cylinder. By comparison, 69.3% AcrySof® IQ Toric SA60T3 eyes achieved ≤ 0.50 D of residual refractive cylinder.

**As control eyes had ≤1.5 D of preoperative Kcyl, results for all toric eyes pooled are not to be compared to control values.

†Difficulty with certain activities without glasses at 6 months, bilateral subjects in the randomized control arm and open label arm safety population.

‡ Derived from clinical evaluation results of the TECNIS® 1-Piece Platform for optical biometry.

§ A-Constant theoretically derived for ultrasound biometry.


1. Black D. Efficacy of hydrophobic acrylic toric IOL to correct astigmatism in cataract patients. Presented at ASCRS  San Diego, Calif. May, 2015. 
2. TECNIS® Toric 1-Piece IOL [package insert]. Santa Ana, Calif. Johnson & Johnson Surgical Vision, Inc.
3. Data on File. Johnson & Johnson Surgical Vision, Inc. 2015.
4. Data on File. Johnson & Johnson Surgical Vision, Inc. 2013.
5. Nagata M, et al. Clinical evaluation of the transparency of hydrophobic acrylic intraocular lens optics. J Cataract Refract Surg. 2010;36(12):2056-2060.
6. Christiansen G, et al. Glistenings in the AcrySof® intraocular lens: Pilot study. J Cataract Refract Surg. 2001;27(5):728-733.
7. Colin J, et al. Incidence of glistenings with the latest generation of yellow-tinted hydrophobic acrylic intraocular lenses. J Cataract Refract Surg. 2012;38(7):1140-1146.
8. Gunenc U, et al. Effects on visual function of glistenings and folding marks in AcrySof® intraocular lenses. J Cataract Refract Surg. 2001;27(10):1611-1614.
9. Van der Mooren M, Franssen L, Piers P. Effects of glistenings in intraocular lenses. Biomed Opt Express. 2013;4(8):1294-1304.
10. Calculated based on Holladay I formula: Holladay JT, Prager TC, Chandler TY, Musgrove KH, Lewis JW, Ruis RS. A three-part system for refining intraocular lens power calculations. J Cataract Refract Surg. 1988;14(1):17-24.



Rx Only


The TECNIS® Toric 1-Piece Posterior Chamber Lens is indicated for the visual correction of aphakia and pre-existing corneal astigmatism of one diopter or greater in adult patients with or without presbyopia in whom a cataractous lens has been removed by phacoemulsification and who desire improved uncorrected distance vision, reduction in residual refractive cylinder, and increased spectacle independence for distance vision. The device is intended to be placed in the capsular bag.


Physicians considering lens implantation should weigh the potential risk/benefit ratio for any circumstances described in the TECNIS® Toric 1-Piece IOL Directions for Use that could increase complications or impact patient outcomes. These circumstances include recurrent severe anterior or posterior segment inflammation or uveitis; surgical difficulties at the time of cataract extraction, which may increase the potential for complications (e.g., persistent bleeding, significant iris damage, uncontrolled positive pressure or significant vitreous prolapse or loss); a compromised eye due to previous trauma or developmental defects in which appropriate support of the IOL is not possible; circumstances that would result in damage to the endothelium during implantation; suspected microbial infection; or patients in whom neither the posterior capsule nor the zonules are intact enough to provide support for the IOL. Children under the age of 2 years are not suitable candidates for intraocular lenses. The clinical study for the TECNIS® Toric 1-Piece IOL did not show evidence of effectiveness for the treatment of preoperative corneal astigmatism of < 1.0 diopter. The TECNIS® Toric 1-Piece IOL should not be placed in the ciliary sulcus. Rotation of the TECNIS® Toric 1-Piece IOL away from its intended axis can reduce its astigmatic correction. Misalignment greater than 30° may increase postoperative refractive cylinder. If necessary, lens repositioning should occur as early as possible prior to lens encapsulation.


Prior to surgery, the surgeon must inform prospective patients of the possible risks and benefits associated with the use of this device and provide a copy of the patient information brochure to the patient. Do not soak or rinse with any solution other than sterile balanced salt solution or sterile normal saline. Do not store in direct sunlight or at greater than  113°F. Carefully remove all viscoelastic and do not over-inflate the capsular bag at the end of the case. Residual viscoelastic and/or over-inflation of the capsular bag may allow the lens to rotate, causing misalignment of the TECNIS® Toric 1-Piece IOL with the intended axis of placement. When the insertion system is used improperly, the haptics of the TECNIS® Toric 1-Piece IOL may become broken. Please refer to the specific instructions for use provided with the insertion instrument or system. The use of methods other than the TECNIS® Toric Calculator to select cylinder power and appropriate axis of implantation were not assessed in the clinical study and may not yield similar results. Accurate keratometry and biometry in addition to the use of the TECNIS® Toric Calculator ( are recommended to achieve optimal visual outcomes. The safety and effectiveness of the toric intraocular lens have not been substantiated in patients with certain preexisting ocular conditions, and intraoperative complications. Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the benefit/risk ratio before implanting a lens in a patient with one or more of these conditions. Preexisting conditions include: choroidal hemorrhage, chronic severe uveitis, concomitant severe eye disease, extremely shallow anterior chamber, medically uncontrolled glaucoma, microphthalmos, non-age-related cataract, proliferative diabetic retinopathy (severe), severe corneal dystrophy, severe optic nerve atrophy, or irregular corneal astigmatism. Intraoperative conditions include: excessive vitreous loss, capsulotomy by any technique other than a circular tear, the presence of radial tears known or suspected at the time of surgery, situations in which the integrity of the circular tear cannot be confirmed by direct visualization, cataract extraction by techniques other than phacoemulsification or liquefaction, situations where the need for a large capsulotomy can be anticipated (e.g., diabetics, retinal detachment in the fellow eye, peripheral retinal pathology, etc.), capsular rupture, significant anterior chamber hyphema, uncontrollable positive intraocular pressure, zonular damage. All preoperative surgical parameters are important when choosing a toric lens for implantation, including preoperative keratometric cylinder (magnitude and axis), incision location, surgeon’s estimated surgically induced astigmatism (SIA) and biometry. The PCA is based on an algorithm that combines published literature (Koch, 2012) and a retrospective analysis of data from a TECNIS® Toric multi-center clinical study. The PCA algorithm for the selection of appropriate cylinder power and axis of implantation was not assessed in a prospective clinical study and may yield results different from those in the TECNIS® Toric intraocular lens labeling. Please refer to the Johnson & Johnson Surgical Vision Toric Calculator user manual for more information. Variability in any of the preoperative measurements can influence patient outcomes and the effectiveness of treating eyes with lower amounts of preoperative corneal astigmatism. All corneal incisions were placed temporally in the clinical study. If the surgeon chooses to place the incision at a different location, outcomes may be different from those obtained in the clinical study. Note that the TECNIS® Toric Calculator incorporates the surgeon’s estimated SIA and incision location when providing IOL options. Do not reuse, resterilize, or autoclave.


Potential adverse events during or following cataract surgery with implantation of an IOL may include but are not limited to: endophthalmitis/intraocular infection, hypopyon, pupillary block, retinal detachment, IOL dislocation, persistent corneal stromal edema, persistent cystoid macular edema, or secondary surgical intervention (including implant repositioning, removal, or other surgical procedure). The most frequently reported cumulative adverse event that occurred during the TECNIS® Toric 1-Piece IOL clinical trial was surgical re-intervention which occurred at a rate of 3.4% (lens repositioning procedures and retinal repair procedures). Other reported events included cystoid macular edema which occurred at a rate of 2.9% and retinal detachment which occurred at a rate of 0.6%.


Rx Only


The Model DK7796 Handpiece is used in combination with the Model 1MTEC30 Cartridge to fold and assist in inserting JJSV Acrylic 1-Piece Intraocular Lenses, ONLY into the capsular bag. 


Do not use the handpiece if the rod tip appears nicked or damaged in any way.


The UNFOLDER® Platinum 1 Series Implantation System should be used ONLY with JJSV Acrylic 1-Piece IOLs. Do not use if the cartridge tip is cracked or split prior to implantation. Never release the plunger until the optic body has been completely released from the cartridge tube.

See Full Indications and Important Safety Information.


Reference the Directions for Use for a complete listing of Indications and Important Safety Information.